FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RIVASTIGMINE TARTRATE
异名/同义词CARBAMIC ACID, N-ETHYL-N-METHYL-, 3-((1S)-1-(DIMETHYLAMINO)ETHYL)PHENYL ESTER, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)
ENA 713
ENA-713
RIVASTIGMINE (AS HYDROGEN TARTRATE)
RIVASTIGMINE ACTAVIS
RIVASTIGMINE BITARTRATE
RIVASTIGMINE HYDROGEN TARTRATE
RIVASTIGMINE HYDROGEN TARTRATE [EMA EPAR]
RIVASTIGMINE HYDROGEN TARTRATE [EP MONOGRAPH]
RIVASTIGMINE HYDROGEN TARTRATE [MART.]
RIVASTIGMINE HYDROGEN TARTRATE [MI]
RIVASTIGMINE HYDROGEN TARTRATE [WHO-DD]
RIVASTIGMINE HYDROGENTARTRATE
RIVASTIGMINE TARTRATE
RIVASTIGMINE TARTRATE [ORANGE BOOK]
RIVASTIGMINE TARTRATE [USP MONOGRAPH]
RIVASTIGMINE TARTRATE [USP-RS]
RIVASTIGMINE TARTRATE [VANDF]
SDZ-ENA 713
SDZ-ENA-713
CAS登记号129101-54-8
物质唯一标识(Unique Ingredient Identifier)9IY2357JPE
分子式C14H22N2O2.C4H6O6
国际化合物标识(International Chemical Identifier,InChI)GWHQHAUAXRMMOT-MBANBULQSA-N
SMILES[C@@H](O)([C@H](C(=O)O)O)C(=O)O.C(Oc1cc([C@@H](N(C)C)C)ccc1)(N(CC)C)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System